Buy Aurobindo Pharma, target Rs 750: Dr CK Narayan

Dr CK Narayan of Chart Advise has a buy call on Aurobindo Pharma Ltd. with a target price of Rs 750. The current market price of Aurobindo Pharma Ltd. is Rs 731.7 Time period given by the analyst is Intra Day when Aurobindo Pharma Ltd. price can reach the defined target. Dr CK Narayan recommended to keep stoploss at Rs 725. Aurobindo Pharma Ltd., incorporated in 1986, is a largecap company with a market cap of Rs 42870.86 crore.

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10038.22 Crore to Sales Value (97.42 % of Total Sales), Export Incentives which contributed Rs 247.87 Crore to Sales Value (2.40 % of Total Sales), Scrap which contributed Rs 13.32 Crore to Sales Value (0.12 % of Total Sales) and Sale of services which contributed Rs 3.74 Crore to Sales Value (0.03 % of Total Sales)for the year ending 31-Mar-2018.

For the quarter ended 30-09-2018, the company has reported a Consolidated sales of Rs 4667.12 Crore, up 11.61 % from last quarter Sales of Rs 4181.56 Crore and up 7.19 % from last year same quarter Sales of Rs 4354.18 Crore Company has reported net profit after tax of Rs 611.20 Crore in latest quarter. The company’s top management includes Dr.M Sivakumaran, Dr.(Mrs.)Avnit Bimal Singh, Mr.K Nithyananda Reddy, Mr.K Ragunathan, Mr.M Madan Mohan Reddy, Mr.M Sitarama Murthy, Mr.N Govindarajan, Mr.P Sarath Chandra Reddy, Mr.P V Ramprasad Reddy, Mrs.Savita Mahajan. Company has BSR & Associates LLP as its auditoRs As on 30-09-2018, the company has a total of 585,907,609 shares outstanding.